FDA Inspection 1017548 — Shanghai Soho-Yiming Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Shanghai Soho-Yiming Pharmaceuticals Co., Ltd. on June 9, 2017 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 9, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shanghai (China)